Correction: MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcome.

Autor: Taeb S; Department of Radiology, School of Paramedical Sciences, Guilan University of Medical Sciences, Rasht, Iran., Rostamzadeh D; Department of Immunology, University of Connecticut Health Center, Farmington, CT, USA., Amini SM; Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran., Rahmati M; Department of Medical Biotechnology, Faculty of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran., Eftekhari M; Department of Medical Biotechnology, Faculty of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran., Safari A; Ionizing and Non-Ionizing Radiation Protection Research Center (INIRPRC), School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.; Department of Radiology, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran., Najafi M; Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran. masoud.najafi@kums.ac.ir.; Medical Biology Research Center, Institute of Health Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran. masoud.najafi@kums.ac.ir.; Medical Technology Research Center, Institute of Health Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran. masoud.najafi@kums.ac.ir.
Jazyk: angličtina
Zdroj: Cancer cell international [Cancer Cell Int] 2024 Aug 03; Vol. 24 (1), pp. 274. Date of Electronic Publication: 2024 Aug 03.
DOI: 10.1186/s12935-024-03461-8
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje